These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 21732678)
1. Chains of magnetosomes extracted from AMB-1 magnetotactic bacteria for application in alternative magnetic field cancer therapy. Alphandéry E; Faure S; Seksek O; Guyot F; Chebbi I ACS Nano; 2011 Aug; 5(8):6279-96. PubMed ID: 21732678 [TBL] [Abstract][Full Text] [Related]
2. Preparation of chains of magnetosomes, isolated from Magnetospirillum magneticum strain AMB-1 magnetotactic bacteria, yielding efficient treatment of tumors using magnetic hyperthermia. Alphandéry E; Guyot F; Chebbi I Int J Pharm; 2012 Sep; 434(1-2):444-52. PubMed ID: 22698862 [TBL] [Abstract][Full Text] [Related]
3. Biocompatible coated magnetosome minerals with various organization and cellular interaction properties induce cytotoxicity towards RG-2 and GL-261 glioma cells in the presence of an alternating magnetic field. Hamdous Y; Chebbi I; Mandawala C; Le Fèvre R; Guyot F; Seksek O; Alphandéry E J Nanobiotechnology; 2017 Oct; 15(1):74. PubMed ID: 29041937 [TBL] [Abstract][Full Text] [Related]
4. A Comparative Study of Receptor-Targeted Magnetosome and HSA-Coated Iron Oxide Nanoparticles as MRI Contrast-Enhancing Agent in Animal Cancer Model. Erdal E; Demirbilek M; Yeh Y; Akbal Ö; Ruff L; Bozkurt D; Cabuk A; Senel Y; Gumuskaya B; Algın O; Colak S; Esener S; Denkbas EB Appl Biochem Biotechnol; 2018 May; 185(1):91-113. PubMed ID: 29082480 [TBL] [Abstract][Full Text] [Related]
5. Biodegraded magnetosomes with reduced size and heating power maintain a persistent activity against intracranial U87-Luc mouse GBM tumors. Alphandéry E; Idbaih A; Adam C; Delattre JY; Schmitt C; Gazeau F; Guyot F; Chebbi I J Nanobiotechnology; 2019 Dec; 17(1):126. PubMed ID: 31870376 [TBL] [Abstract][Full Text] [Related]
6. The effect of iron-chelating agents on Magnetospirillum magneticum strain AMB-1: stimulated growth and magnetosome production and improved magnetosome heating properties. Alphandéry E; Amor M; Guyot F; Chebbi I Appl Microbiol Biotechnol; 2012 Nov; 96(3):663-70. PubMed ID: 22707052 [TBL] [Abstract][Full Text] [Related]
7. Development of non-pyrogenic magnetosome minerals coated with poly-l-lysine leading to full disappearance of intracranial U87-Luc glioblastoma in 100% of treated mice using magnetic hyperthermia. Alphandéry E; Idbaih A; Adam C; Delattre JY; Schmitt C; Guyot F; Chebbi I Biomaterials; 2017 Oct; 141():210-222. PubMed ID: 28689117 [TBL] [Abstract][Full Text] [Related]
8. Effects of pulsed magnetic field on the formation of magnetosomes in the Magnetospirillum sp. strain AMB-1. Pan W; Chen C; Wang X; Ma Q; Jiang W; Lv J; Wu LF; Song T Bioelectromagnetics; 2010 Apr; 31(3):246-51. PubMed ID: 19780093 [TBL] [Abstract][Full Text] [Related]
9. Chains of magnetosomes with controlled endotoxin release and partial tumor occupation induce full destruction of intracranial U87-Luc glioma in mice under the application of an alternating magnetic field. Alphandéry E; Idbaih A; Adam C; Delattre JY; Schmitt C; Guyot F; Chebbi I J Control Release; 2017 Sep; 262():259-272. PubMed ID: 28713041 [TBL] [Abstract][Full Text] [Related]
10. [Magnetically based enhancement of nanoparticle uptake in tumor cells: combination of magnetically induced cell labeling and magnetic heating]. Kettering M; Winter J; Zeisberger M; Alexiou C; Bremer-Streck S; Bergemann C; Kaiser WA; Hilger I Rofo; 2006 Dec; 178(12):1255-60. PubMed ID: 17136650 [TBL] [Abstract][Full Text] [Related]
11. Enhanced antitumor efficacy of biocompatible magnetosomes for the magnetic hyperthermia treatment of glioblastoma. Le Fèvre R; Durand-Dubief M; Chebbi I; Mandawala C; Lagroix F; Valet JP; Idbaih A; Adam C; Delattre JY; Schmitt C; Maake C; Guyot F; Alphandéry E Theranostics; 2017; 7(18):4618-4631. PubMed ID: 29158849 [TBL] [Abstract][Full Text] [Related]
12. Non-pyrogenic highly pure magnetosomes for efficient hyperthermia treatment of prostate cancer. Nguyen TN; Chebbi I; Le Fèvre R; Guyot F; Alphandéry E Appl Microbiol Biotechnol; 2023 Feb; 107(4):1159-1176. PubMed ID: 36633624 [TBL] [Abstract][Full Text] [Related]
13. Smart Magnetotactic Bacteria Enable the Inhibition of Neuroblastoma under an Alternating Magnetic Field. Chen C; Wang P; Chen H; Wang X; Halgamuge MN; Chen C; Song T ACS Appl Mater Interfaces; 2022 Mar; 14(12):14049-14058. PubMed ID: 35311270 [TBL] [Abstract][Full Text] [Related]
16. Assemblies of aligned magnetotactic bacteria and extracted magnetosomes: what is the main factor responsible for the magnetic anisotropy? Alphandéry E; Ding Y; Ngo AT; Wang ZL; Wu LF; Pileni MP ACS Nano; 2009 Jun; 3(6):1539-47. PubMed ID: 19459692 [TBL] [Abstract][Full Text] [Related]
17. Stable pharmaceutical composition of cryo-protected non-pyrogenic isotonic chains of magnetosomes for efficient tumor cell destruction at 45 ± 1 °C under alternating magnetic field or ultrasound application. Nguyen TN; Chebbi I; Le Fèvre R; Guyot F; Alphandéry E Nanoscale; 2024 Oct; 16(40):18984-18997. PubMed ID: 39297787 [TBL] [Abstract][Full Text] [Related]
18. High-frequency, magnetic-field-responsive drug release from magnetic nanoparticle/organic hybrid based on hyperthermic effect. Hayashi K; Ono K; Suzuki H; Sawada M; Moriya M; Sakamoto W; Yogo T ACS Appl Mater Interfaces; 2010 Jul; 2(7):1903-11. PubMed ID: 20568697 [TBL] [Abstract][Full Text] [Related]
19. Cellular level loading and heating of superparamagnetic iron oxide nanoparticles. Kalambur VS; Longmire EK; Bischof JC Langmuir; 2007 Nov; 23(24):12329-36. PubMed ID: 17960940 [TBL] [Abstract][Full Text] [Related]
20. Natural magnetic nanoparticle containing droplet for smart drug delivery and heat treatment. Lee S; Ahn JH; Choi H; Seo JM; Cho D; Koo K Annu Int Conf IEEE Eng Med Biol Soc; 2015 Aug; 2015():3541-4. PubMed ID: 26737057 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]